Teleflex Incorporated
TFX
Pozycja w akcjach
#3230
Teleflex Incorporated is a global medical technology company dedicated to... Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Cena akcji
$130.11
Kapitalizacja rynkowa
$5.51B
Zmiana (1 dzień)
0.40%
Zmiana (1 rok)
-0.33%
Kraj
US
Handel Teleflex Incorporated (TFX)
Kategoria
Healthcare
Wskaźnik P/E dla Teleflex Incorporated (TFX)
Wskaźnik P/E na dzień October 2026 TTM: -5.30
Według najnowszych raportów finansowych i ceny akcji Teleflex Incorporated, obecny wskaźnik P/E (TTM) wynosi -5.30. Na koniec 2023 wskaźnik P/E wynosił 32.87.
Historia wskaźnika P/E dla Teleflex Incorporated od 2000 do 2026
Wskaźnik P/E na koniec każdego roku
| Rok | Wskaźnik P/E | Zmień |
|---|---|---|
| 2026 (TTM) | -5.30 | -104.43% |
| 2024 | 119.64 | 263.93% |
| 2023 | 32.87 | 1.97% |
| 2022 | 32.24 | 1.85% |
| 2021 | 31.65 | -44.52% |
| 2020 | 57.06 | 51.40% |
| 2019 | 37.69 | -35.92% |
| 2018 | 58.81 | -19.89% |
| 2017 | 73.41 | 149.60% |
| 2016 | 29.41 | 31.84% |
| 2015 | 22.31 | -11.85% |
| 2014 | 25.31 | -1.03% |
| 2013 | 25.57 | -266.80% |
| 2012 | -15.33 | -299.68% |
| 2011 | 7.68 | -28.10% |
| 2010 | 10.68 | 51.16% |
| 2009 | 7.06 | -57.34% |
| 2008 | 16.56 | -1.95% |
| 2007 | 16.89 | -8.27% |
| 2006 | 18.41 | -3.49% |
| 2005 | 19.08 | -91.25% |
| 2004 | 218.11 | 1,134.01% |
| 2003 | 17.68 | 32.21% |
| 2002 | 13.37 | -18.05% |
| 2001 | 16.31 | 5.58% |
| 2000 | 15.45 | 0.00% |
Wskaźnik P/E dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/E | Różnica wskaźnika P/E | Kraj |
|---|---|---|---|
| 47.48 | -996.61% |
US
|
|
| 27.43 | -617.86% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | -1,174.29% |
US
|
|
| - | - |
CH
|
Jak odczytywać wskaźnik P/E?
Wskaźnik Cena/Zysk (P/E) mierzy relację między ceną akcji firmy a jej zyskiem na akcję.
Niski, ale dodatni P/E oznacza firmę osiągającą wysokie zyski względem obecnej wyceny i może być niedowartościowana. Wysoki ujemny (bliski 0) P/E wskazuje na duże straty.
Firmy z P/E powyżej 30 lub ujemnym uznaje się zazwyczaj za "akcje wzrostowe", czyli inwestorzy oczekują wzrostu lub przyszłych zysków.
Firmy z dodatnim P/E poniżej 10 uznaje się za "akcje wartościowe", co oznacza, że są już bardzo dochodowe, ale bez dużego potencjału wzrostu.